# Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

> **NCT05717712** · PHASE1 · RECRUITING · sponsor: **Capital Medical University** · enrollment: 18 (estimated)

## Conditions studied

- Oncolytic Virus
- Diffuse Intrinsic Pontine Glioma
- Adverse Drug Event

## Interventions

- **BIOLOGICAL:** Ad-TD-nsIL12

## Key facts

- **NCT ID:** NCT05717712
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-04
- **Primary completion:** 2025-01-04
- **Final completion:** 2028-01-04
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05717712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05717712, "Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05717712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*